A journey through anticoagulant therapies in the treatment of left ventricular thrombus in post-COVID-19 heparin-induced thrombocytopenia: a case report.
Hematology
; 27(1): 318-321, 2022 Dec.
Article
in English
| MEDLINE | ID: covidwho-1713441
ABSTRACT
BACKGROUND:
Heparin-induced thrombocytopenia (HIT) is an immune-mediated adverse drug reaction associated with thrombosis. Clinical scoring systems and the presence of anti-platelet factor 4 (anti-PF4)/heparin antibodies determine the diagnosis. CASE PRESENTATION A 57-year-old man who was treated with acenocoumarol due to a chronic left ventricular thrombus was admitted to the hospital for severe SARS-CoV-2 pneumonia and pulmonary embolism. The patient was started on bemiparin and discharged. Left lower limb acute arterial ischemia and thrombocytopenia were diagnosed 18 days later. Computed tomography angiography revealed a large left ventricular thrombus and multiple arterial thrombi. Left femoral-popliteal thromboembolectomy was performed. Anti-PF4/heparin antibodies confirmed an HIT diagnosis. Fondaparinux (7.5â mg/24â h) was initiated, but cardiac surgery was necessary. Bivalirudin was used during surgery, with an initial load (1.25â mg/kg) and maintenance infusion (2.5â mg/kg/h). The cardiac thrombus was extracted, but the patient experienced a postsurgical myocardial infarction. Percutaneous cardiovascular intervention (PCI) required a bivalirudin load (0.75â mg/kg) and maintenance infusion (1.75â mg/kg/h). No coronary lesions were detected, and argatroban was started afterwards (0.5â µg/kg/min). When the platelet count exceeded 100 × 109/L, acenocoumarol was initiated. Thereupon, acetylsalicylic acid (100â mg/24â h) was added. No other complications have been reported to date.CONCLUSION:
The clinical presentation of intraventricular and multiple arterial thrombi is remarkable. SARS-CoV-2 infection likely contributed to a hypercoagulable state. The management of patients with HIT undergoing cardiac surgery is challenging. If surgery cannot be delayed, then treatment with bivalirudin is recommended. Additionally, this drug is recommended for PCI. Bivalirudin is safe and well-tolerated in both procedures.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Peptide Fragments
/
Arginine
/
Pipecolic Acids
/
Sulfonamides
/
Thrombocytopenia
/
Thrombosis
/
Heparin
/
Hirudins
/
Percutaneous Coronary Intervention
/
SARS-CoV-2
Type of study:
Case report
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
/
Male
/
Middle aged
Language:
English
Journal:
Hematology
Journal subject:
Hematology
Year:
2022
Document Type:
Article
Affiliation country:
16078454.2022.2043572
Similar
MEDLINE
...
LILACS
LIS